

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.79834507 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.79834507 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.31090662 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.23804944 |
| 5 | detection of other organism (GO:0098543) | 4.83372578 |
| 6 | leukocyte aggregation (GO:0070486) | 4.57943871 |
| 7 | detection of bacterium (GO:0016045) | 4.56128934 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.55444301 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.51606623 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 4.27801185 |
| 11 | detection of external biotic stimulus (GO:0098581) | 4.18268534 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.09269416 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.06131254 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.06131254 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.06131254 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.06131254 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.06131254 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.06131254 |
| 19 | negative regulation of phagocytosis (GO:0050765) | 4.05990182 |
| 20 | respiratory burst (GO:0045730) | 4.03001422 |
| 21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.98350666 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96348594 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.95486594 |
| 24 | positive regulation of B cell differentiation (GO:0045579) | 3.93517677 |
| 25 | response to peptidoglycan (GO:0032494) | 3.93332544 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.91853023 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84988833 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.79524032 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.77945846 |
| 30 | detection of biotic stimulus (GO:0009595) | 3.72808498 |
| 31 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.71361163 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.64721152 |
| 33 | regulation of B cell differentiation (GO:0045577) | 3.62692315 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.58815598 |
| 35 | negative regulation of cell killing (GO:0031342) | 3.58815598 |
| 36 | macrophage activation (GO:0042116) | 3.55058233 |
| 37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.54750722 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.48983189 |
| 39 | regulation of leukocyte degranulation (GO:0043300) | 3.44765937 |
| 40 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.43542418 |
| 41 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.42019169 |
| 42 | germinal center formation (GO:0002467) | 3.40147105 |
| 43 | response to fungus (GO:0009620) | 3.39345804 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.38009104 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 3.36522422 |
| 46 | microglial cell activation (GO:0001774) | 3.35435110 |
| 47 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.34739826 |
| 48 | cellular extravasation (GO:0045123) | 3.34348590 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.33408383 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.32063880 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 3.31742028 |
| 52 | neutrophil activation (GO:0042119) | 3.31175065 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 3.30081018 |
| 54 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.28788777 |
| 55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.28000922 |
| 56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.27439533 |
| 57 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.25165392 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.23819236 |
| 59 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.23200719 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.22766454 |
| 61 | positive regulation of interferon-alpha production (GO:0032727) | 3.21861994 |
| 62 | leukocyte cell-cell adhesion (GO:0007159) | 3.17213340 |
| 63 | granulocyte activation (GO:0036230) | 3.14898865 |
| 64 | positive thymic T cell selection (GO:0045059) | 3.14865161 |
| 65 | defense response to fungus (GO:0050832) | 3.14733779 |
| 66 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.12193806 |
| 67 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10852310 |
| 68 | regulation of interferon-alpha production (GO:0032647) | 3.08071364 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.07000019 |
| 70 | T cell migration (GO:0072678) | 3.02494853 |
| 71 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.02406958 |
| 72 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.00848014 |
| 73 | negative regulation of interleukin-6 production (GO:0032715) | 3.00201683 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.99139163 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98720864 |
| 76 | response to type I interferon (GO:0034340) | 2.98561357 |
| 77 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.96025178 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.95660017 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95501377 |
| 80 | type I interferon signaling pathway (GO:0060337) | 2.95168792 |
| 81 | cellular response to type I interferon (GO:0071357) | 2.95168792 |
| 82 | B cell mediated immunity (GO:0019724) | 2.95110901 |
| 83 | defense response to protozoan (GO:0042832) | 2.91186508 |
| 84 | myeloid dendritic cell activation (GO:0001773) | 2.90802777 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90084569 |
| 86 | response to host immune response (GO:0052572) | 2.90084569 |
| 87 | regulation of regulated secretory pathway (GO:1903305) | 2.89846359 |
| 88 | T-helper 1 type immune response (GO:0042088) | 2.87790690 |
| 89 | leukocyte degranulation (GO:0043299) | 2.86888491 |
| 90 | response to protozoan (GO:0001562) | 2.86684055 |
| 91 | negative regulation of interleukin-12 production (GO:0032695) | 2.85425647 |
| 92 | actin nucleation (GO:0045010) | 2.83301527 |
| 93 | leukocyte mediated cytotoxicity (GO:0001909) | 2.82360223 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 2.81942476 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81565550 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80365912 |
| 97 | negative regulation of innate immune response (GO:0045824) | 2.80169387 |
| 98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.78367499 |
| 99 | response to host (GO:0075136) | 2.78367499 |
| 100 | response to host defenses (GO:0052200) | 2.78367499 |
| 101 | pentose-phosphate shunt (GO:0006098) | 2.77977932 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.77957156 |
| 103 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77646677 |
| 104 | positive regulation of mast cell degranulation (GO:0043306) | 2.77646677 |
| 105 | negative thymic T cell selection (GO:0045060) | 2.77584512 |
| 106 | regulation of T cell tolerance induction (GO:0002664) | 2.77519985 |
| 107 | natural killer cell mediated immunity (GO:0002228) | 2.77223893 |
| 108 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.77223893 |
| 109 | mannose metabolic process (GO:0006013) | 2.76337496 |
| 110 | regulation of tolerance induction (GO:0002643) | 2.76089856 |
| 111 | negative regulation of type 2 immune response (GO:0002829) | 2.76002008 |
| 112 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.75723804 |
| 113 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.75606023 |
| 114 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.73991990 |
| 115 | neutrophil chemotaxis (GO:0030593) | 2.73177615 |
| 116 | pinocytosis (GO:0006907) | 2.70376625 |
| 117 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.70265391 |
| 118 | positive regulation of type 2 immune response (GO:0002830) | 2.69451275 |
| 119 | hepatocyte apoptotic process (GO:0097284) | 2.68843400 |
| 120 | regulation of response to interferon-gamma (GO:0060330) | 2.68617505 |
| 121 | negative T cell selection (GO:0043383) | 2.66095654 |
| 122 | tolerance induction (GO:0002507) | 2.65829554 |
| 123 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.65778788 |
| 124 | neutrophil migration (GO:1990266) | 2.65633671 |
| 125 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.61990785 |
| 126 | mast cell activation (GO:0045576) | 2.61088074 |
| 127 | cellular response to zinc ion (GO:0071294) | 2.60570273 |
| 128 | response to interleukin-15 (GO:0070672) | 2.58510419 |
| 129 | barbed-end actin filament capping (GO:0051016) | 2.57600307 |
| 130 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.56811822 |
| 131 | myeloid leukocyte mediated immunity (GO:0002444) | 2.55380580 |
| 132 | interferon-gamma production (GO:0032609) | 2.53936756 |
| 133 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52782493 |
| 134 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.52778638 |
| 135 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.51637007 |
| 136 | thymic T cell selection (GO:0045061) | 2.51340740 |
| 137 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.51291570 |
| 138 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.51291570 |
| 139 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50014271 |
| 140 | dendritic cell differentiation (GO:0097028) | 2.49302618 |
| 141 | myeloid leukocyte activation (GO:0002274) | 2.47140355 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.46242414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.13338661 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92546491 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.29847897 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.23007314 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03577535 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.01004097 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.98262938 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.96569203 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.84714468 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82206974 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.78885727 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76731841 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74787949 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.73409570 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.69783447 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65033610 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47806971 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42883757 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41241771 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.39956097 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34890099 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.30641763 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.28426081 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.24474445 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.21745591 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.21416348 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.19234257 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.17594962 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.17169689 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.12109522 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02781833 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01049528 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.98361064 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93431466 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86747456 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.86424243 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81633799 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79489164 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73869338 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71133810 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68095788 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64248840 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.61363955 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55697133 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55568859 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51123453 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48646885 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47837785 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47783988 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46192863 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.45430360 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44702062 |
| 53 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42656958 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40223625 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39117902 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37713841 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37279660 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36172875 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35547352 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34995872 |
| 61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34432084 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33209113 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32973492 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30954842 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29932526 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24495139 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23923035 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23634633 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21243109 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19700963 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18377171 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17304711 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15640337 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15045818 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14910867 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14174861 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13305270 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11736625 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11560513 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11480301 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10239193 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08139615 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06564389 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06292051 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06012714 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05034774 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03604196 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03075581 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00538175 |
| 90 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00490259 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99500428 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99185145 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98881396 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97348875 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97240917 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97130897 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95947432 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95568371 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94838915 |
| 100 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.94601029 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94151728 |
| 102 | P68_20966046_ChIP-Seq_HELA_Human | 0.93709891 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92010236 |
| 104 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91288169 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90642133 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90242859 |
| 107 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89002453 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88760296 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88360669 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87729157 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87445824 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85386393 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83352326 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81343930 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80875605 |
| 116 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.78982753 |
| 117 | P300_27268052_Chip-Seq_Bcells_Human | 0.78606239 |
| 118 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.77980337 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77754817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.63465673 |
| 2 | MP0003303_peritoneal_inflammation | 3.22640722 |
| 3 | MP0003436_decreased_susceptibility_to | 3.09978268 |
| 4 | MP0000685_abnormal_immune_system | 2.95795846 |
| 5 | MP0009785_altered_susceptibility_to | 2.81293747 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.72882890 |
| 7 | MP0001800_abnormal_humoral_immune | 2.62936779 |
| 8 | MP0005387_immune_system_phenotype | 2.61846253 |
| 9 | MP0001790_abnormal_immune_system | 2.61846253 |
| 10 | MP0002419_abnormal_innate_immunity | 2.60487290 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.57417842 |
| 12 | MP0005671_abnormal_response_to | 2.56168740 |
| 13 | MP0005025_abnormal_response_to | 2.50645001 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.47555434 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.40157703 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.39929624 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.38313285 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.37163583 |
| 19 | MP0002723_abnormal_immune_serum | 2.35157267 |
| 20 | MP0005451_abnormal_body_composition | 2.34180058 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.31722296 |
| 22 | MP0001819_abnormal_immune_cell | 2.30608243 |
| 23 | MP0008260_abnormal_autophagy | 2.23337692 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.15160062 |
| 25 | MP0006082_CNS_inflammation | 2.11928789 |
| 26 | MP0002396_abnormal_hematopoietic_system | 2.10617638 |
| 27 | MP0002405_respiratory_system_inflammati | 2.10002432 |
| 28 | MP0002398_abnormal_bone_marrow | 2.05319893 |
| 29 | MP0003763_abnormal_thymus_physiology | 2.04537275 |
| 30 | MP0009278_abnormal_bone_marrow | 1.96634772 |
| 31 | MP0000716_abnormal_immune_system | 1.91246607 |
| 32 | MP0001873_stomach_inflammation | 1.88962099 |
| 33 | MP0004947_skin_inflammation | 1.87516838 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.85146780 |
| 35 | MP0002006_tumorigenesis | 1.82511790 |
| 36 | MP0009840_abnormal_foam_cell | 1.81643055 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.79414316 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.78281302 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.76843406 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.76821626 |
| 41 | MP0002722_abnormal_immune_system | 1.74446132 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.74033605 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.74033605 |
| 44 | MP0001853_heart_inflammation | 1.66180675 |
| 45 | MP0003724_increased_susceptibility_to | 1.66126829 |
| 46 | MP0002429_abnormal_blood_cell | 1.65028685 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.64321280 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.63982328 |
| 49 | MP0004510_myositis | 1.63593974 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.62669781 |
| 51 | MP0010307_abnormal_tumor_latency | 1.60191697 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.46718996 |
| 53 | MP0000858_altered_metastatic_potential | 1.45333688 |
| 54 | MP0008469_abnormal_protein_level | 1.42637512 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.40575981 |
| 56 | MP0005310_abnormal_salivary_gland | 1.39295572 |
| 57 | MP0002933_joint_inflammation | 1.38547172 |
| 58 | MP0005174_abnormal_tail_pigmentation | 1.34645746 |
| 59 | MP0002132_abnormal_respiratory_system | 1.34073377 |
| 60 | MP0003866_abnormal_defecation | 1.33320560 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.32612663 |
| 62 | MP0004381_abnormal_hair_follicle | 1.30280363 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.28624592 |
| 64 | MP0003448_altered_tumor_morphology | 1.22476035 |
| 65 | MP0000490_abnormal_crypts_of | 1.21465773 |
| 66 | MP0004883_abnormal_blood_vessel | 1.17225310 |
| 67 | MP0000569_abnormal_digit_pigmentation | 1.13465160 |
| 68 | MP0005023_abnormal_wound_healing | 1.08119736 |
| 69 | MP0000343_altered_response_to | 1.07837810 |
| 70 | MP0008004_abnormal_stomach_pH | 1.06229365 |
| 71 | MP0005164_abnormal_response_to | 1.05536202 |
| 72 | MP0003690_abnormal_glial_cell | 1.04460017 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.03605265 |
| 74 | MP0001851_eye_inflammation | 0.98657261 |
| 75 | MP0003075_altered_response_to | 0.95035225 |
| 76 | MP0009764_decreased_sensitivity_to | 0.94408706 |
| 77 | MP0003091_abnormal_cell_migration | 0.93965141 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.93524395 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.92924127 |
| 80 | MP0000604_amyloidosis | 0.92535481 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.89796939 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.86777077 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.84793536 |
| 84 | MP0003693_abnormal_embryo_hatching | 0.84076450 |
| 85 | MP0000371_diluted_coat_color | 0.82390546 |
| 86 | MP0000609_abnormal_liver_physiology | 0.80230991 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 0.79565508 |
| 88 | MP0009763_increased_sensitivity_to | 0.78191528 |
| 89 | MP0002254_reproductive_system_inflammat | 0.77406814 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.75343457 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 0.75328512 |
| 92 | MP0005166_decreased_susceptibility_to | 0.74403681 |
| 93 | MP0001663_abnormal_digestive_system | 0.72500607 |
| 94 | MP0003045_fibrosis | 0.72384907 |
| 95 | MP0003795_abnormal_bone_structure | 0.68638946 |
| 96 | MP0000249_abnormal_blood_vessel | 0.68506325 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.67717016 |
| 98 | MP0003329_amyloid_beta_deposits | 0.67526469 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.66880091 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.66031907 |
| 101 | MP0000598_abnormal_liver_morphology | 0.65324315 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65130758 |
| 103 | MP0001849_ear_inflammation | 0.64228133 |
| 104 | MP0000313_abnormal_cell_death | 0.64062014 |
| 105 | MP0005390_skeleton_phenotype | 0.63947708 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.62389539 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.61768195 |
| 108 | MP0008874_decreased_physiological_sensi | 0.60747590 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.60252643 |
| 110 | MP0005360_urolithiasis | 0.59462473 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.59393706 |
| 112 | MP0004858_abnormal_nervous_system | 0.58998025 |
| 113 | MP0003077_abnormal_cell_cycle | 0.58962111 |
| 114 | MP0002928_abnormal_bile_duct | 0.58781544 |
| 115 | MP0003828_pulmonary_edema | 0.57083997 |
| 116 | MP0009643_abnormal_urine_homeostasis | 0.56216821 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.55421665 |
| 118 | MP0002095_abnormal_skin_pigmentation | 0.54793827 |
| 119 | MP0002009_preneoplasia | 0.53934216 |
| 120 | MP0008007_abnormal_cellular_replicative | 0.53314694 |
| 121 | MP0008873_increased_physiological_sensi | 0.53279829 |
| 122 | MP0003111_abnormal_nucleus_morphology | 0.52975587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.75266621 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.61799698 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.92425206 |
| 4 | Myositis (HP:0100614) | 4.11265177 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.08583707 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.02975488 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86163865 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.83022139 |
| 9 | Recurrent viral infections (HP:0004429) | 3.66054365 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.63201356 |
| 11 | Nasal polyposis (HP:0100582) | 3.55632782 |
| 12 | Chronic otitis media (HP:0000389) | 3.42480837 |
| 13 | Recurrent skin infections (HP:0001581) | 3.41675780 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.36607100 |
| 15 | IgM deficiency (HP:0002850) | 3.27458316 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.24422325 |
| 17 | Obstructive lung disease (HP:0006536) | 3.24422325 |
| 18 | Gingivitis (HP:0000230) | 3.20996114 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.18990768 |
| 20 | Cellulitis (HP:0100658) | 3.18028934 |
| 21 | Pustule (HP:0200039) | 3.15967737 |
| 22 | Orchitis (HP:0100796) | 3.14167073 |
| 23 | Thrombocytosis (HP:0001894) | 3.13145430 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.11900804 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.10569146 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 3.08163562 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.05655777 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.04480098 |
| 29 | Recurrent bronchitis (HP:0002837) | 3.04258827 |
| 30 | Petechiae (HP:0000967) | 3.02431594 |
| 31 | Meningitis (HP:0001287) | 2.97719315 |
| 32 | Stomatitis (HP:0010280) | 2.94955590 |
| 33 | Amyloidosis (HP:0011034) | 2.93049019 |
| 34 | Inflammation of the large intestine (HP:0002037) | 2.88822689 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 2.87595370 |
| 36 | Periodontitis (HP:0000704) | 2.80428892 |
| 37 | Abnormality of B cell number (HP:0010975) | 2.79963967 |
| 38 | B lymphocytopenia (HP:0010976) | 2.79963967 |
| 39 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78402568 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.78402568 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.77754516 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.76894352 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.76894352 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.73552540 |
| 45 | Optic neuritis (HP:0100653) | 2.73552540 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.66307258 |
| 47 | Vasculitis (HP:0002633) | 2.65966657 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.65256834 |
| 49 | Colitis (HP:0002583) | 2.61881311 |
| 50 | Thyroiditis (HP:0100646) | 2.61750581 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.61448411 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61265532 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61265532 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61265532 |
| 55 | Leukocytosis (HP:0001974) | 2.61015416 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.58592638 |
| 57 | Increased IgE level (HP:0003212) | 2.57927790 |
| 58 | Episodic fever (HP:0001954) | 2.57296738 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.56493185 |
| 60 | Osteomyelitis (HP:0002754) | 2.54103341 |
| 61 | Abnormal platelet function (HP:0011869) | 2.53641521 |
| 62 | Impaired platelet aggregation (HP:0003540) | 2.53641521 |
| 63 | Arterial thrombosis (HP:0004420) | 2.52908079 |
| 64 | Thoracic kyphosis (HP:0002942) | 2.48543183 |
| 65 | Increased serum ferritin (HP:0003281) | 2.48533034 |
| 66 | Hypochromic anemia (HP:0001931) | 2.48416979 |
| 67 | Panhypogammaglobulinemia (HP:0003139) | 2.47836581 |
| 68 | Eosinophilia (HP:0001880) | 2.45074654 |
| 69 | Abnormality of T cells (HP:0002843) | 2.43864984 |
| 70 | Urticaria (HP:0001025) | 2.42744514 |
| 71 | Lymphopenia (HP:0001888) | 2.40494192 |
| 72 | Anorexia (HP:0002039) | 2.40048944 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.37682221 |
| 74 | Epistaxis (HP:0000421) | 2.34751466 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.32451820 |
| 76 | Peritonitis (HP:0002586) | 2.29126021 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.28676940 |
| 78 | Hematochezia (HP:0002573) | 2.28084725 |
| 79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27610227 |
| 80 | Abnormality of the thoracic spine (HP:0100711) | 2.26828273 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.26322885 |
| 82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23187290 |
| 83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23187290 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23187290 |
| 85 | Granulocytopenia (HP:0001913) | 2.22867876 |
| 86 | Gingival bleeding (HP:0000225) | 2.20963397 |
| 87 | Chronic diarrhea (HP:0002028) | 2.20076831 |
| 88 | Combined immunodeficiency (HP:0005387) | 2.19153343 |
| 89 | Chest pain (HP:0100749) | 2.17275989 |
| 90 | Pulmonary embolism (HP:0002204) | 2.16338254 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.15968064 |
| 92 | Purpura (HP:0000979) | 2.15671012 |
| 93 | Prolonged bleeding time (HP:0003010) | 2.14037003 |
| 94 | Gangrene (HP:0100758) | 2.11452511 |
| 95 | Abnormality of eosinophils (HP:0001879) | 2.11020950 |
| 96 | Abnormality of the fingertips (HP:0001211) | 2.10741863 |
| 97 | T lymphocytopenia (HP:0005403) | 2.10251652 |
| 98 | Increased IgM level (HP:0003496) | 2.09167922 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07487979 |
| 100 | Agammaglobulinemia (HP:0004432) | 2.06949814 |
| 101 | Skin ulcer (HP:0200042) | 2.06654315 |
| 102 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05689122 |
| 103 | Osteolytic defects of the hand bones (HP:0009699) | 2.05689122 |
| 104 | Abnormality of T cell number (HP:0011839) | 2.05594217 |
| 105 | Disinhibition (HP:0000734) | 2.04444515 |
| 106 | Myocardial infarction (HP:0001658) | 2.03159905 |
| 107 | Abnormal platelet volume (HP:0011876) | 2.03028105 |
| 108 | Encephalitis (HP:0002383) | 2.01492814 |
| 109 | Polycythemia (HP:0001901) | 2.00475185 |
| 110 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.00194890 |
| 111 | Keratoconjunctivitis sicca (HP:0001097) | 1.99770366 |
| 112 | Recurrent sinusitis (HP:0011108) | 1.99128033 |
| 113 | Sepsis (HP:0100806) | 1.99031663 |
| 114 | J-shaped sella turcica (HP:0002680) | 1.98730792 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 1.98672213 |
| 116 | Abnormality of the endocardium (HP:0004306) | 1.98519314 |
| 117 | Abnormality of the pleura (HP:0002103) | 1.98153948 |
| 118 | Gastrointestinal infarctions (HP:0005244) | 1.96829519 |
| 119 | Slow saccadic eye movements (HP:0000514) | 1.96510345 |
| 120 | Fatigue (HP:0012378) | 1.95886358 |
| 121 | Glomerulopathy (HP:0100820) | 1.95262029 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.95067633 |
| 123 | Loss of speech (HP:0002371) | 1.95059452 |
| 124 | Hemoptysis (HP:0002105) | 1.94659224 |
| 125 | Abnormality of the peritoneum (HP:0002585) | 1.93356710 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92013414 |
| 127 | Malnutrition (HP:0004395) | 1.90848518 |
| 128 | Cheilitis (HP:0100825) | 1.87891546 |
| 129 | Acne (HP:0001061) | 1.87456208 |
| 130 | Viral hepatitis (HP:0006562) | 1.85202515 |
| 131 | Microcytic anemia (HP:0001935) | 1.84398544 |
| 132 | Vertigo (HP:0002321) | 1.83858069 |
| 133 | Neuronal loss in central nervous system (HP:0002529) | 1.83425734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.43617301 |
| 2 | PRPF4B | 3.21610942 |
| 3 | ERN1 | 2.92298493 |
| 4 | TYK2 | 2.57043339 |
| 5 | BLK | 2.49625741 |
| 6 | STK10 | 2.38801406 |
| 7 | ZAP70 | 2.37270285 |
| 8 | PKN2 | 2.32711380 |
| 9 | TBK1 | 2.30160225 |
| 10 | IRAK4 | 2.24747067 |
| 11 | EEF2K | 2.20928956 |
| 12 | TRIB3 | 2.17897857 |
| 13 | KIT | 2.10609206 |
| 14 | TESK2 | 1.99684563 |
| 15 | TGFBR2 | 1.93791055 |
| 16 | MAP3K10 | 1.93649745 |
| 17 | GRK6 | 1.93000126 |
| 18 | TESK1 | 1.90526140 |
| 19 | JAK3 | 1.90211499 |
| 20 | BTK | 1.88466340 |
| 21 | MAP3K14 | 1.84277124 |
| 22 | EPHB1 | 1.72103091 |
| 23 | CSF1R | 1.68735295 |
| 24 | TAOK2 | 1.66895202 |
| 25 | TXK | 1.65135448 |
| 26 | FGR | 1.63031938 |
| 27 | JAK1 | 1.62721385 |
| 28 | IKBKE | 1.59778788 |
| 29 | MAP2K3 | 1.58332367 |
| 30 | SYK | 1.53001116 |
| 31 | RIPK4 | 1.45460023 |
| 32 | SMG1 | 1.43516512 |
| 33 | TEC | 1.39883001 |
| 34 | IKBKB | 1.39833178 |
| 35 | LRRK2 | 1.39113723 |
| 36 | TAOK3 | 1.36043361 |
| 37 | HCK | 1.34701721 |
| 38 | KDR | 1.33964197 |
| 39 | IRAK2 | 1.33560429 |
| 40 | ITK | 1.32880137 |
| 41 | PTK6 | 1.31855521 |
| 42 | CSK | 1.30967030 |
| 43 | IRAK3 | 1.30893011 |
| 44 | SCYL2 | 1.30418253 |
| 45 | LCK | 1.26703743 |
| 46 | FGFR4 | 1.23282628 |
| 47 | PIM2 | 1.19842341 |
| 48 | SIK3 | 1.17753147 |
| 49 | MAP3K11 | 1.14524801 |
| 50 | CLK1 | 1.14356010 |
| 51 | KSR2 | 1.12468631 |
| 52 | IRAK1 | 1.11795747 |
| 53 | MAP3K6 | 1.09266545 |
| 54 | MARK2 | 1.08959163 |
| 55 | TTN | 1.08876862 |
| 56 | PAK4 | 1.08218225 |
| 57 | FES | 1.08002378 |
| 58 | FLT3 | 1.07393310 |
| 59 | PIM1 | 1.07010865 |
| 60 | NEK2 | 1.06691234 |
| 61 | PRKD2 | 1.06086691 |
| 62 | JAK2 | 0.99805289 |
| 63 | LYN | 0.96658444 |
| 64 | RPS6KA4 | 0.95993328 |
| 65 | FGFR3 | 0.92667558 |
| 66 | TNK2 | 0.90092779 |
| 67 | CDK12 | 0.88340304 |
| 68 | CDC42BPA | 0.87946366 |
| 69 | PDPK1 | 0.87926069 |
| 70 | CHUK | 0.85625964 |
| 71 | GRK7 | 0.76397005 |
| 72 | MAP3K13 | 0.76376691 |
| 73 | ICK | 0.76236124 |
| 74 | SIK2 | 0.73102801 |
| 75 | MAP3K8 | 0.71813634 |
| 76 | YES1 | 0.69976427 |
| 77 | BMPR2 | 0.67590944 |
| 78 | TRPM7 | 0.67137007 |
| 79 | MAPK12 | 0.64825138 |
| 80 | ALK | 0.64493421 |
| 81 | MAPK7 | 0.62917500 |
| 82 | CDK4 | 0.61918715 |
| 83 | TAOK1 | 0.60032892 |
| 84 | NME2 | 0.58864206 |
| 85 | STK4 | 0.58585595 |
| 86 | CDK6 | 0.57366559 |
| 87 | MAP3K3 | 0.56772181 |
| 88 | PDK1 | 0.56397216 |
| 89 | MAP3K7 | 0.56173344 |
| 90 | MARK3 | 0.54754602 |
| 91 | RPS6KA6 | 0.54543996 |
| 92 | MAP3K5 | 0.54229476 |
| 93 | MOS | 0.54113706 |
| 94 | MAPKAPK2 | 0.52960330 |
| 95 | BMX | 0.51460043 |
| 96 | MATK | 0.50804809 |
| 97 | MAP2K6 | 0.50709423 |
| 98 | CAMK1D | 0.50606513 |
| 99 | PRKG2 | 0.48957162 |
| 100 | RPS6KL1 | 0.47620383 |
| 101 | RPS6KC1 | 0.47620383 |
| 102 | SGK3 | 0.47020403 |
| 103 | MAP3K2 | 0.46909321 |
| 104 | SIK1 | 0.46048380 |
| 105 | MAPK11 | 0.45063056 |
| 106 | MAPKAPK3 | 0.44112175 |
| 107 | EGFR | 0.42496569 |
| 108 | PRKCD | 0.41711494 |
| 109 | PASK | 0.41064066 |
| 110 | EIF2AK3 | 0.39033902 |
| 111 | PIK3CG | 0.38623036 |
| 112 | MAP2K4 | 0.37643833 |
| 113 | ATR | 0.37293603 |
| 114 | MAPK4 | 0.37086978 |
| 115 | RET | 0.36988454 |
| 116 | DYRK1B | 0.36758701 |
| 117 | ABL1 | 0.35547916 |
| 118 | RPS6KA2 | 0.34652114 |
| 119 | NEK9 | 0.34306334 |
| 120 | MAP3K1 | 0.32557576 |
| 121 | RPS6KA1 | 0.32322981 |
| 122 | RPS6KB2 | 0.32178976 |
| 123 | PRKCQ | 0.31933877 |
| 124 | RAF1 | 0.28876088 |
| 125 | RIPK1 | 0.28622790 |
| 126 | EPHA3 | 0.26855365 |
| 127 | PDGFRB | 0.26634185 |
| 128 | HIPK2 | 0.26453299 |
| 129 | FYN | 0.25549504 |
| 130 | MAP3K12 | 0.24795674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02089563 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.75605762 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50113720 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.38743616 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.36419139 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.35734841 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32388449 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24965635 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.14137651 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06077169 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01532082 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.99180720 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82806007 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.82376465 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82191636 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.81348630 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79631580 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79365149 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.78164929 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.63491726 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.63406564 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.61343500 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.60421307 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59443853 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58748984 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.50895274 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46387821 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43518033 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.42565503 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.42253132 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39829915 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37207011 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.35370211 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35079631 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34411883 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32750191 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31717428 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30921574 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19555614 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19019403 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18687044 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18187376 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17310261 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.17005369 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.15469251 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.11754378 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.11651758 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08514138 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08473901 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00911016 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00687626 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99184578 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98244811 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.97268118 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95506914 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.94576609 |
| 57 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92795865 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91514988 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89739635 |
| 60 | DNA replication_Homo sapiens_hsa03030 | 0.88162234 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83269392 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.81377808 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80913099 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80569259 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79798688 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.79786947 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76771504 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.75034814 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71648817 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70795419 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69786030 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69272316 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69243516 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68550881 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68447830 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.67827743 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67482701 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66142471 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66122867 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65090460 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63693839 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63243593 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.63030073 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61458117 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60788758 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59896118 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57999635 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56697094 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55591323 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54049117 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53590675 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.53305650 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53081755 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52644754 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51451784 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.50878438 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50629040 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49481909 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49094450 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48674236 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.48552727 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48063804 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46998327 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46253670 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46044683 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45534406 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.44794237 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43401138 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43332102 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41129252 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40948260 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39230977 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38312609 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38303350 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.38018681 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36639153 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35965358 |
| 118 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35555801 |
| 119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33024696 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31323224 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31245344 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29990293 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.29774071 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29548805 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28995486 |

